Bolt Threads is a biotechnology company that specializes in developing and commercializing sustainable materials. The company's innovative approach involves using proprietary technologies to create renewable fabrics and fibers, such as Mylo and Microsilk, which are inspired by natural processes and designed to reduce the environmental impact of the textile industry.

Bolt Threads

Biomatter develops proteins and enzymes with Intelligent Architecture™ for health and sustainable manufacturing. The company provides solutions from initial concept to protein production.

Biomatter

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Austin Che

Tom Knight

Jason Kelly

Barry Canton

Reshma Shetty

Ginkgo Bioworks Holdings, Inc.

VAIA Technologies provides automated inspection solutions for product and process quality and reliability. The company utilizes machine vision, automation, and robotics to deliver integrated solutions.

VAIA Technologies

Bolt Threads is on a mission to create way better materials for a way better world, developing sustainable solutions for the world’s best apparel, footwear, and beauty brands including adidas and Stella McCartney. With nature as our inspiration, our scientists and engineers invent materials, like Mylo™ and b-silk™ protein, that put us on a path toward a more sustainable future. We are creative, inclusive, and multidisciplinary. We embrace curious minds that are resilient and can adapt in a rapidly evolving environment. We are committed to advancing diversity, equity, and inclusion. We are at the start of something big and are looking to build a collaborative and diverse team to bring the future to life. Bolt Threads has offices in Berkeley, Calif. and Arnhem, NL and has been selected as a Fast Company Most Innovative company every year since 2018.We keep our LinkedIn job postings current. If you're interested in a career at Bolt, please view our open positions on the Jobs tab.

Metric
Company Name	Bolt Threads	Biomatter	Ginkgo Bioworks Holdings, Inc.	VAIA Technologies
Symbol			DNA
MSH ID	COM:BOLTTHREADS	COM:BIOMATTER	COM:GINKGOBIOWORKS	COM:VAIA-TECH
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Consumer Goods	Technology	Healthcare	Commercial & Professional Services
Industry	Biotechnology	Biotechnology	Biotechnology	Manufacturing
Country	US	LT	US	US
Stage			Grant	Seed
Employee Count	50		1.22K
Website	boltthreads.com	biomatter.com	ginkgobioworks.com	vaia-tech.com
LinkedIn	bolt-threads	biomatter	ginkgo-bioworks
Founders

Metric
Market Cap	283.09M	725.64M
Enterprise Value
Monthly Web Traffic		20.69K
Web Traffic Growth		-0.17
Valuation
Raised Capital			450K

Metric
Revenue			251.46M
Revenue (LTM)
Revenue (NTM)
Gross Profit			142.64M
EBITDA			-600.68M
Operating Income			-672.23M
Net Income			-892.87M
EPS			-0.46
Diluted EPS			-0.46
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.75
Operating Profit Margin			-3.34
EBITDA Margin			-2.39
Net Profit Margin			-3.55
Return on Equity			-0.65
Return on Assets			-0.54
Return on Capital Employed			-0.51

COM:BOLTTHREADS

Bolt Threads

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-2.78
P/B Ratio			1.90
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			93.70
EV Multiple			-1.34

Metric
Days Sales Outstanding			73.17
Days Payables Outstanding			50.57
Days Inventory Outstanding			0.27
Operating Cycle			46.33
Cash Conversion Cycle			-7.39
Asset Turnover			0.15

Metric
Operating Cash Flow			-295.50M
Free Cash Flow			-336.30M
Cash Flow to Debt			-0.63
Operating Cash Flow/Sales			-1.14
Free Cash Flow Yield			-0.16

Metric
Cash & Equivalents			948.86M
Accounts Receivable			50.07M
Inventory			46K
Goodwill			49.24M
Debt to Capitalization			0.35
Debt to Assets			0.20
Current Ratio			6.78
Quick Ratio			5.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.94
R&D to Revenue			2.05
SG&A to Revenue			1.32